Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

Библиографические подробности
Главные авторы:	Karavitaki, N, Wass, J
Формат:	Conference item
Опубликовано:	2010

Схожие документы

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
по: Karavitaki, N, и др.
Опубликовано: (2013)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
по: Karavitaki, N, и др.
Опубликовано: (2013)

The outcome of macroprolactinomas resistant to dopamine agonists
по: Coculescu, M, и др.
Опубликовано: (2005)

Efficacy and safety of rapid escalation of cabergoline in comparison to conventional regimen for macroprolactinoma: A prospective, randomized trial
по: Ashu Rastogi, и др.
Опубликовано: (2012-01-01)

Clinical Outcome of Invasive Pituitary Prolactinomas Treated with Cabergoline
по: Bassam M Flamerz Arkawazi
Опубликовано: (2020-01-01)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
по: Herring, N, и др.
Опубликовано: (2009)

A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
по: Soni, A, и др.
Опубликовано: (2008)

Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
по: Lambert, K, и др.
Опубликовано: (2017)

Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
по: Lambert, K, и др.
Опубликовано: (2017)

Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea
по: Souha S Elabd, и др.
Опубликовано: (2018-02-01)

An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
по: Ali S. Alzahrani, и др.
Опубликовано: (2023-12-01)

A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
по: Michelle Maher, и др.
Опубликовано: (2018-07-01)

Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
по: Reddy, R, и др.
Опубликовано: (2011)

Non-adenomatous pituitary tumours.
по: Karavitaki, N, и др.
Опубликовано: (2009)

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.
по: Rogers, A, и др.
Опубликовано: (2014)

Nonfunctioning pituitary adenomas: the Oxford experience.
по: Wass, J, и др.
Опубликовано: (2009)

Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.
по: Arnold, J, и др.
Опубликовано: (2008)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
по: Arnold, JR, и др.
Опубликовано: (2009)

The postoperative monitoring of nonfunctioning pituitary adenomas.
по: Wass, J, и др.
Опубликовано: (2011)

The postoperative monitoring of nonfunctioning pituitary adenomas
по: Wass, J, и др.
Опубликовано: (2011)

Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction
по: Pankaj Agrawal, и др.
Опубликовано: (2022-12-01)

Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience
по: Guadalupe Vargas-Ortega, и др.
Опубликовано: (2022-07-01)

Treatment of pituitary tumors: history.
по: Thanabalasingham, G, и др.
Опубликовано: (2005)

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline
по: Emre Bozkirli, и др.
Опубликовано: (2013-01-01)

Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma
по: DL Goede, и др.
Опубликовано: (2006-04-01)

The modern management of macroprolactinomas.
по: Grossman, A
Опубликовано: (1991)

Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction
по: Tania Sundra, и др.
Опубликовано: (2024-03-01)

Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features.
по: Suliman, S, и др.
Опубликовано: (2007)

MANAGEMENT OF ENDOCRINE DISEASE: Pituitary tumour apoplexy.
по: Capatina, C, и др.
Опубликовано: (2014)

Reply to Commentary on "Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction"
по: Pankaj Agrawal, и др.
Опубликовано: (2023-03-01)

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
по: Barber, T, и др.
Опубликовано: (2011)

Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report
по: Shaojian Lin, и др.
Опубликовано: (2022-08-01)

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
по: Fernandez, A, и др.
Опубликовано: (2010)

Macroprolactinoma in an adolescent female with primary amenorrhoea
по: Ning Zhang, и др.
Опубликовано: (2024-12-01)

Pituitary apoplexy in non-functioning pituitary adenomas: Long term follow up is important because of significant numbers of tumour recurrences
по: Pal, A, и др.
Опубликовано: (2011)

Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences.
по: Pal, A, и др.
Опубликовано: (2011)

CABERGOLINE IN PRACTICAL MAMMOLOGY
по: I. V. Vysotskaya, и др.
Опубликовано: (2016-12-01)

Cabergoline or bromocriptine for prolactinoma?
по: Nicolás Triantafilo, и др.
Опубликовано: (2016-09-01)

Macroprolactinoma resistente aos agonistas dopaminérgicos: relato de caso Macroprolactinoma resistant to dopamine agonists: a case report
по: Rosana Maria dos Reis, и др.
Опубликовано: (2004-09-01)

Thyrotropin-secreting pituitary tumor presenting with congestive heart failure and good response to dopaminergic agonist cabergoline
по: Yu-Hsi Kao, и др.
Опубликовано: (2013-11-01)